Article
Antiviral drug resistance.
PI perspective - 1 Dec 1995
Abstract excerpt
Representatives from pharmaceutical companies discussed cross resistance to protease inhibitors (PI) at a meeting sponsored by Project Inform and the Gay Men's Health Crisis of New York. Observations included the following: PI cross-resistance is still largely an unknown, there has been a correlation between genotypic and phenotypic resistance to PI with clinical drug failure, initial saquinavir treatment may not...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
